Published by Sean Farrell on 8th June 2020
(Sharecast News) - AstraZeneca has approached Gilead Sciences of the US about a potential merger to create a $240bn drugmaker, according to a report.
URL: http://www.digitallook.com/dl/news/story/30762174/...